AI assistant
aTYR PHARMA INC — Director's Dealing 2015
May 6, 2015
34337_dirs_2015-05-06_97b49fd3-639e-4d9f-be6e-946b279516de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2015-05-06
Reporting Person: Sofinnova Venture Partners IX, L.P. (10% Owner)
Reporting Person: Sofinnova Management IX, L.L.C. (10% Owner)
Reporting Person: HEALY JAMES (10% Owner)
Reporting Person: POWELL MICHAEL (10% Owner)
Reporting Person: AKKARAJU SRINIVAS (10% Owner)
Reporting Person: Mehra Anand (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series E Redeemable Convertible Preferred Stock | $ | Common Stock (14968722) | Direct |
Footnotes
F1: The aggregate number of shares of the Issuer's Preferred Stock held by the Reporting Person converts into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares convert into Common Stock on a 1-for-9.6814 basis.
F2: The shares of Preferred Stock are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX. Dr. James I. Healy, Michael F. Powell, Ph.D., Dr. Srinivas Akkaraju and Dr. Anand Mehra are managing members of SM IX and exercise shared voting and investment power with respect to the shares owned by SVP IX. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.